Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Elisabeth G. Celius"'
Autor:
Asia-Sophia Wolf, Anthony Ravussin, Marton König, Mathias H. Øverås, Guri Solum, Ingrid Fadum Kjønstad, Adity Chopra, Trygve Holmøy, Hanne F. Harbo, Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Einar August Høgestøl, Jon Torgils Vaage, Elisabeth G. Celius, Fridtjof Lund-Johansen, Ludvig A. Munthe, Gro Owren Nygaard, Siri Mjaaland
Publikováno v:
JCI Insight, Vol 8, Iss 12 (2023)
Immune responses in people with multiple sclerosis (pwMS) receiving disease-modifying therapies (DMTs) have been of significant interest throughout the COVID-19 pandemic. Lymphocyte-targeting immunotherapies, including anti-CD20 treatments and sphing
Externí odkaz:
https://doaj.org/article/5ba69269a3e644d2844eed3988e93d9c
Autor:
Antonio Bertolotto, Rafael Arroyo, Elisabeth G. Celius, Giancarlo Comi, Eva Kubala Havrdova, William David Honeycutt, Samuel F. Hunter, Guillermo Izquierdo, Barbara Kornek, Tamara Miller, Dimos D. Mitsikostas, Barry A. Singer, Tjalf Ziemssen, Luke Chung, Nadia Daizadeh, Salman Afsar, Lobat Hashemi, Peter Senior
Publikováno v:
Neurology and Therapy, Vol 9, Iss 2, Pp 443-457 (2020)
Plain Language Summary This study looked at alemtuzumab, an approved treatment for multiple sclerosis (MS). People who receive alemtuzumab may develop thyroid problems. The researchers wanted to know whether people who developed thyroid problems with
Externí odkaz:
https://doaj.org/article/3bcc37fc46e84de69be4eb2c49df7148
Autor:
Lara Kular, Yun Liu, Sabrina Ruhrmann, Galina Zheleznyakova, Francesco Marabita, David Gomez-Cabrero, Tojo James, Ewoud Ewing, Magdalena Lindén, Bartosz Górnikiewicz, Shahin Aeinehband, Pernilla Stridh, Jenny Link, Till F. M. Andlauer, Christiane Gasperi, Heinz Wiendl, Frauke Zipp, Ralf Gold, Björn Tackenberg, Frank Weber, Bernhard Hemmer, Konstantin Strauch, Stefanie Heilmann-Heimbach, Rajesh Rawal, Ulf Schminke, Carsten O. Schmidt, Tim Kacprowski, Andre Franke, Matthias Laudes, Alexander T. Dilthey, Elisabeth G. Celius, Helle B. Søndergaard, Jesper Tegnér, Hanne F. Harbo, Annette B. Oturai, Sigurgeir Olafsson, Hannes P. Eggertsson, Bjarni V. Halldorsson, Haukur Hjaltason, Elias Olafsson, Ingileif Jonsdottir, Kari Stefansson, Tomas Olsson, Fredrik Piehl, Tomas J. Ekström, Ingrid Kockum, Andrew P. Feinberg, Maja Jagodic
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-15 (2018)
The human leukocyte antigen (HLA) haplotype DRB1*15:01 is the major risk factor for multiple sclerosis (MS). Here the authors find that DNA methylation at HLA-DRB1 gene mediates the effect of DRB1*15:01 and of a protective HLA variant on HLA-DRB1 exp
Externí odkaz:
https://doaj.org/article/31861db392bf46669b4a789c9a333f74
Autor:
Sigurgeir Olafsson, Pernilla Stridh, Steffan Daniël Bos, Andres Ingason, Jack Euesden, Patrick Sulem, Gudmar Thorleifsson, Omar Gustafsson, Ari Johannesson, Arni J. Geirsson, Arni V. Thorsson, Bardur Sigurgeirsson, Bjorn Runar Ludviksson, Elias Olafsson, Helga Kristjansdottir, Jon G. Jonasson, Jon Hjaltalin Olafsson, Kjartan B. Orvar, Rafn Benediktsson, Ragnar Bjarnason, Sjofn Kristjansdottir, Thorarinn Gislason, Trausti Valdimarsson, Evgenia Mikaelsdottir, Snaevar Sigurdsson, Stefan Jonsson, Thorunn Rafnar, Dag Aarsland, Srdjan Djurovic, Tormod Fladby, Gun Peggy Knudsen, Elisabeth G. Celius, Kjell-Morten Myhr, Gerdur Grondal, Kristjan Steinsson, Helgi Valdimarsson, Sigurdur Bjornsson, Unnur S. Bjornsdottir, Einar S Bjornsson, Bjorn Nilsson, Ole A. Andreassen, Lars Alfredsson, Jan Hillert, Ingrid Skelton Kockum, Gisli Masson, Unnur Thorsteinsdottir, Daniel F. Gudbjartsson, Hreinn Stefansson, Haukur Hjaltason, Hanne F. Harbo, Tomas Olsson, Ingileif Jonsdottir, Kari Stefansson
Publikováno v:
npj Genomic Medicine, Vol 2, Iss 1, Pp 1-12 (2017)
Multiple sclerosis: Sequence variants discovered by meta-analysis informed by genetic correlation Combining studies and comparing across diseases turned up 14 novel gene variants linked to multiple sclerosis (MS). A team led by Kári Stefánsson and
Externí odkaz:
https://doaj.org/article/9096113a85cf464487746a5332bdc34b
Autor:
Sigrid A. de Rodez Benavent, Gro O. Nygaard, Kristian B. Nilsen, Lars Etholm, Piotr Sowa, Marte Wendel-Haga, Hanne F. Harbo, Liv Drolsum, Bruno Laeng, Emilia Kerty, Elisabeth G. Celius
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Introduction: Autonomic nervous system (ANS) symptoms are prevalent in multiple sclerosis (MS) as is neurodegeneration. Our aim was to explore the occurrence of ANS symptoms and retinal neurodegeneration in a newly diagnosed MS population with tools
Externí odkaz:
https://doaj.org/article/20a93dce6fd84226991f5cd1c115863a
Autor:
Krista Barclay, Robert Carruthers, Anthony Traboulsee, Ann D. Bass, Christopher LaGanke, Antonio Bertolotto, Aaron Boster, Elisabeth G. Celius, Jérôme de Seze, Dionisio Dela Cruz, Mario Habek, Jong-Mi Lee, Volker Limmroth, Sven G. Meuth, Celia Oreja-Guevara, Patricia Pagnotta, Cindy Vos, Tjalf Ziemssen, Darren P. Baker, Bart Van Wijmeersch
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Multiple sclerosis (MS) is a chronic autoimmune neurological disease that typically affects young adults, causing irreversible physical disability and cognitive impairment. Alemtuzumab, administered intravenously as 2 initial courses of 12 mg/day (5
Externí odkaz:
https://doaj.org/article/5a2d464a5167440db92790a49c321afc
Autor:
Cortese, Rosa, Battaglini, Marco, Ferran, Prados, Alessia, Bianchi, Lukas, Haider, Anu, Jacob, Jacqueline, Palace, Silvia, Messina, Friedemann, Paul, Jens, Wuerfel, Romain, Marignier, Françoise, Durand-Dubief, Carolina de Medeiros Rimkus, Dagoberto, Callegaro, Douglas Kazutoshi Sato, Massimo, Filippi, Maria Assunta Rocca, Laura, Cacciaguerra, Alex, Rovira, Jaume, Sastre-Garriga, Georgina, Arrambide, Yaou, Liu, Yunyun, Duan, Claudio, Gasperini, Carla, Tortorella, Serena, Ruggieri, Maria Pia Amato, Ulivelli, Monica, Sergiu, Groppa, Matthias, Grothe, Sara, Llufriu, Maria, Sepulveda, Carsten, Lukas, Barbara, Bellenberg, Ruth, Schneider, Piotr, Sowa, Elisabeth, G Celius, Anne-Katrin, Proebstel, Özgür, Yaldizli, Jannis, Müller, Bruno, Stankoff, Benedetta, Bodini, Luca, Carmisciano, Maria Pia Sormani, Frederik, Barkhof, DE STEFANO, Nicola, Olga, Ciccarelli
Publikováno v:
the MAGNIMS Study Group 2023, ' Clinical and MRI measures to identify non-acute MOG-antibody disease in adults ', Brain, vol. 146, no. 6, pp. 2489-2501 . https://doi.org/10.1093/brain/awac480
MRI and clinical features of myelin oligodendrocyte glycoprotein (MOG)-antibody disease may overlap with those of other inflammatory demyelinating conditions posing diagnostic challenges, especially in non-acute phases and when serologic testing for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dab35f38202038ca6e2e133c0f026398
https://research.vumc.nl/en/publications/e321144b-2134-4661-90ab-2c2b055587cf
https://research.vumc.nl/en/publications/e321144b-2134-4661-90ab-2c2b055587cf
Autor:
Nina Grytten, Kjell-Morten Myhr, Elisabeth G. Celius, Espen Benjaminsen, Rune Midgard, Anita Vatne, Jan H. Aarseth, Janne Mannseth, Øivind Torkildsen
Publikováno v:
Multiple Sclerosis and Related Disorders
Background: Cancer is a major cause of death, but how cancer influences mortality risk in Multiple Sclerosis (MS) is unclear. Objectives: Determine all-cause mortality and mortality following a cancer diagnosis among MS patients compared with matched
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c49f21f2ed1b2fd6690d95cb3ca20cd1
https://hdl.handle.net/11250/3048666
https://hdl.handle.net/11250/3048666
Autor:
Asia-Sophia Wolf, Anthony Ravussin, Marton König, Mathias H. Øverås, Guri Solum, Ingrid Fadum Kjønstad, Adity Chopra, Trygve Holmøy, Hanne F. Harbo, Silje Watterdal Syversen, Kristin Kaasen Jørgensen, Einar August Høgestøl, Jon Torgils Vaage, Elisabeth G. Celius, Fridtjof Lund-Johansen, Ludvig A. Munthe, Gro Owren Nygaard, Siri Mjaaland
Immune responses in people with multiple sclerosis (pwMS) on disease-modifying therapies (DMTs) have been of significant interest throughout the COVID-19 pandemic. Lymphocyte-targeting immunotherapies including anti-CD20 treatments and sphingosine-1-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed4724bf248371230df8fe83cadcbe49
https://doi.org/10.1101/2022.08.25.22279202
https://doi.org/10.1101/2022.08.25.22279202
Autor:
Karine Eid, Øivind Torkildsen, Jan Aarseth, Elisabeth G. Celius, Marianna Cortese, Trygve Holmøy, Akash Kapali, Kjell-Morten Myhr, Cecilie F. Torkildsen, Stig Wergeland, Nils Erik Gilhus, Marte-Helene Bjørk
Publikováno v:
Journal of Neurology
Background Knowledge concerning exposure to abuse in adulthood and in pregnancy in people with multiple sclerosis (MS) is sparse. Objective To determine the occurrence of adult abuse and abuse in relation to pregnancy in women with MS and their risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3147872dcecb7ddd8b675a53f76be2db
http://hdl.handle.net/10852/97193
http://hdl.handle.net/10852/97193